Epigenetic Silencing of SOX15 Is Controlled by miRNAs rather than Methylation in Papillary Thyroid Cancer

Table 1

Clinicopathological characteristics of patients.

Clinicopathological characteristics		(%)
Sex	Female	44 (84.62)
	Male	8 (15.38)
Age	≤55	35 (67.31)
	>55	16 (30.77)
	Unknown	1 (1.92)
TNM stage	TNM1	34 (65.38)
	TNM2	7 (13.46)
	TNM3	6 (11.54)
	TNM4	3 (5.77)
	Unknown	2 (3.85)
Lymphatic invasion	Present	17 (32.69)
	Absent	34 (65.38)
	Unknown	1 (1.92)
Vascular invasion	Present	7 (13.46)
	Absent	44 (84.61)
	Unknown	1 (1.92)
Perineural invasion	Present	6 (11.54)
	Absent	45 (86.54)
	Unknown	1 (1.92)
Capsule invasion	Present	17 (32.69)
	Absent	33 (63.46)
	Unknown	2 (3.85)
Calcification	Present	26 (50)
	Absent	21 (40.38)
	Unknown	5 (9.62)
Tumor diameter	≤2	34 (65.38)
	2-4	15 (28.85)
	>4	2 (3.85)
	Unknown	1 (1.92)
Histologic type	Papillary	47 (90.38)
	Medullar	1 (1.92)
	Follicular	1 (1.92)
	Anaplastic	1 (1.92)
	Unknown	2 (3.85)